eTHOS: Enhancing the health of NHS Staff. A trial to assess an employee health screening clinic for NHS staff

eTHOS: Enhancing the Health of NHS Staff: A randomised controlled pilot trial of an employee health screening clinic for NHS staff.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN10237475

Enrollment

480

Registered

2019-12-09

Start date

2020-12-02

Completion date

Unknown

Last updated

2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

NHS Staff are the participants in this trial and are considered healthy, although unknown conditions may be diagnosed as a result of the intervention screening Other

Interventions

All those randomised to the intervention arm will attend a staff health screening clinic. It will consist of two stages: (1) a screening assessment for musculoskeletal, mental and the NHS health check

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Must be an employee of one of the participating NHS Trusts (an employee is defined as any individual employed (i.e. undertaking work for payment) by the participating Trust)

Exclusion criteria

Exclusion criteria: 1. Previous attendees of the current Queen Elizabeth Hospital Birmingham pilot screening clinic 2. Paramedics, community NHS staff and volunteers

Design outcomes

Secondary

Measure	Time frame
Feasibility outcomes: 1. Referrals to recommended services at 52 weeks 2. Acceptability of intervention to participants and health clinic staff measured using face to face interviews and focus groups. These will take place from randomisation to the end of 52 week follow up 3. Feasibility of trial processes measured using completeness of relevant data items, interviews at 52 weeks 4. Indication of intervention contamination measured using resource usage collected at baseline, 26 & 52 weeks Outcomes related to the definitive RCT: 6. Absenteeism with reasons at 26 & 52 weeks (including self-report and employee records) 7. Presenteeism measured using WHO-HPQ questionnaire at 26 & 52 weeks (self-complete) 8. HRQoL measured using EuroQol EQ5D 5-level at 26 & 52 weeks (self-complete) 9. Healthcare and occupational health service utilisation at 26 & 52 weeks (self-reported) 10. Resource use/costs (questionnaire to patients & trial data) at 26 & 52 weeks	—

Measure

Time frame

Feasibility outcomes: 1. Referrals to recommended services at 52 weeks 2. Acceptability of intervention to participants and health clinic staff measured using face to face interviews and focus groups. These will take place from randomisation to the end of 52 week follow up 3. Feasibility of trial processes measured using completeness of relevant data items, interviews at 52 weeks 4. Indication of intervention contamination measured using resource usage collected at baseline, 26 & 52 weeks Outcomes related to the definitive RCT: 6. Absenteeism with reasons at 26 & 52 weeks (including self-report and employee records) 7. Presenteeism measured using WHO-HPQ questionnaire at 26 & 52 weeks (self-complete) 8. HRQoL measured using EuroQol EQ5D 5-level at 26 & 52 weeks (self-complete) 9. Healthcare and occupational health service utilisation at 26 & 52 weeks (self-reported) 10. Resource use/costs (questionnaire to patients & trial data) at 26 & 52 weeks

—

Primary

Measure	Time frame
1. Recruitment rate at 26 weeks 2. Referral to recommended services at 26 weeks (intervention arm only) 3. Uptake of recommended services at 26 weeks (self-report) (intervention arm only)	—

Countries

England, United Kingdom

Contacts

Public ContactSheriden Bevan

s.bevan@bham.ac.uk+44 (0)121 414 8137

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Jun 27, 2026